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 ABSTRACT 
Objectives Randomised controlled trials are important for evaluating healthcare 
interventions, but recruitment can be difficult. Studies of potential participants’ 
perspectives on trial participation are accumulating but their collective contribution is not 
obvious. In 2007 we conducted a meta-ethnographic synthesis of people’s reasons for 
accepting or declining participation. This paper reports a second synthesis, conducted 
separately on the same topic, using studies published subsequently. It discusses both the 
substantive findings and the methodological implications for updating meta-ethnographies.   
Methods Systematic searches identified relevant papers published between 1996 and 2005 
(first synthesis), then 2005 and 2010 (second synthesis). We used a meta-ethnographic 
interpretive process of translation to examine the relationships between study findings.  
Findings The two syntheses were broadly compatible, but the line of argument developed in 
the second more clearly highlighted how potential participants’ health states and healthcare 
situations at the time of recruitment could interact with other considerations. In particular 
they could influence the nature and significance for trial entry decisions of people’s 
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judgements about: their communication and relationship with trial recruiters; the personal 
implications of trial interventions and processes; and the “common good” (helping others) 
and what their non/participation might say about their identity.   
 
Conclusions Our work highlights the need for trialists to consider potential participants’ 
health and healthcare situations when designing recruitment approaches. It also provides 
the first empirical insights on the process of updating meta-ethnographies that we are 
currently aware of. Approaches to updating meta-ethnographies need further investigation.  
 
Introduction 
Randomised controlled trials (RCTs) can generate valuable knowledge about the effects of 
clinical interventions, but trialists often struggle to recruit sufficient participants.1  
Numerous qualitative research studies have generated insightful findings into potential 
participants’ perspectives on trial recruitment,2-5 but their collective contribution is hard to 
ascertain without a formal review. To complement broader systematic summaries of 
evidence and issues relating to trial recruitment6,7 we had undertaken, in 2007, a meta-
ethnographic synthesis that specifically aimed to identify and build new conceptual 
knowledge about peoples’ reasons for accepting or declining participation in trials (we 
focused on phase III RCTs - trials of interventions in which basic safety and efficacy checks 
have already been completed). 
 
This first meta-ethnography, covering papers published between 1996 and 2005,8  had 
established that people’s personal circumstances at the time of being invited to participate 
in a trial were salient to participation decisions, and that being able to perceive some 
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personal benefit from trial participation was clearly associated with willingness to take part. 
The synthesis also highlighted that potential participants could identify personal benefits 
and harms in both trial processes and interventions. Figure 1 illustrates the conceptual 
model developed from the first synthesis. 
 
[Figure 1 here] 
 
In December 2010 we re-ran the original literature searches and identified 12 papers 
published since September 2005 that fulfilled the original inclusion criteria. Although there 
have been a number of papers that consider methodological  issues relating to meta-
ethnographies,9-11 we found no published guidance on how to update a meta-ethnography. 
After considering a range of possible options, we decided to conduct a new, “stand-alone” 
meta-ethnography. Our decision reflected a concern to avoid forcing the findings from the 
recent studies into the model generated by the earlier synthesis, and to facilitate clear 
identification of the additional insights generated by the more recent studies. We further 
reasoned that by comparing the two syntheses and reflecting on the strengths and 
limitations of this ‘standalone’ approach, we could inform a much-needed methodological 
discussion about updating meta-ethnographies. 
 
Methods 
Meta-ethnography facilitates an “essentially interpretive and inductive” approach to 
synthesising studies. It centres on “translating” the findings of individual qualitative studies 
so they can be considered in relation to one another. This allows re-interpretation and 
construction of interpretations accumulatively across studies.12,13 
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While planning and conducting the second meta-ethnography, we avoided referring back to 
the findings of the first, but on its completion we compared the resultant syntheses and 
reflected on the ‘standalone’ update process. We focus now on the methods of the second 
synthesis. 
 
Searching and identification of relevant studies 
Medline, EMBASE, CINAHL, ASSIA, PsychInfo, SocAbs and the Cochrane Library were 
searched using the comprehensive search strategy developed for the first synthesis to 
identify English language publications (September 2005 –December 2010) reporting 
qualitative data on people’s own accounts for accepting or declining participation in specific 
phase III RCTs. The reference lists of relevant papers were also searched.  
 
One reviewer (SM) assessed the abstracts of the 2965 references from the bibliographic 
searches and identified 38 as potentially relevant. Two reviewers (SM, VE) screened the full 
text versions of these using a structured assessment form (paperwork available on request). 
The inclusion criteria specified that studies must have examined people’s own accounts of 
what influenced their decision to participate or not in the trial. This restriction allowed us to 
focus on papers offering rich insights into peoples’ reasons for accepting or declining 
participation. The 12 papers that met the inclusion criteria are summarised in Table 1. They 
report on 9 separate research studies associated with 12 RCTs.  
 
Analysis & synthesis 
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Two reviewers (SM and VE) read and systematically extracted data from included papers, 
and discussed study findings and interpretations with a third reviewer (MC) throughout the 
process. 
 
We initially organised papers in chronological order and followed Noblit and Hare12 in 
focusing on the findings, concepts and themes used by the papers’ authors. We generated a 
list of key categories that served as the basis for comparing the similarities and differences 
across studies. This enabled us to produce a “reciprocal translation” - a comparison of the 
concepts used in the different studies12 (example in Box 1). The translated concepts were 
integrated in a new interpretation or ‘line of argument.’12  
[Insert Box 1] 
 
It became clear that the health conditions and situations that people were dealing with at 
the time of trial invitation were important. We therefore decided to re-group the papers 
according to the broad types of health conditions and situations that were represented: 
situations perceived as urgent and/or life threatening; established long-term conditions; and 
recently diagnosed long-term conditions. We then examined the key concepts thematically 
within these groups, attending as far as possible to the contextual aspects of particular 
studies. (Alternative approaches to ordering and grouping studies are possible within meta-
ethnography, although their relative merits are not fully understood9).  
 
 
Findings  
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We developed a ‘line of argument’ synthesis12 that identified how potential participants’ 
health and healthcare situations at the time of recruitment can interact with other 
considerations to influence trial participation decisions. These situations had implications 
particularly for people’s decision-influencing judgements about: (1) their communication 
and relationships with trial recruiters; (2) the trial interventions and processes; and (3) their 
concerns about helping others and what their decisions about trial participation might say 
about them as people (referred to below as ‘common good and identity implications’). 
 
We summarise the study findings that underpin this synthesis below. To reduce repetition in 
the text we provide authors’ details only when we introduce the papers, then use the paper 
descriptor labels from Table 1.  
 
[Insert Table 1] 
Situations perceived as urgent and/or life-threatening  
Seven papers studied people asked to participate in a trial in situations that most perceived 
as urgent and/or life-threatening (for themselves and/or their children):  “pre-term labour” 
papers (a) and (b),3,14 “perinatal” paper,15 “breast and ovarian” papers (a) and (b),16,17 
“stroke” paper,18 leukaemia” paper.5  
 
The “pre-term labour” papers studied women who were asked to participate in a trial when 
they were experiencing pre-term labour or pre-labour membrane rupture. The “perinatal” 
paper studied parents of babies with life-threatening health problems. The authors of these 
three papers highlighted a dominant sense of “fear” amongst potential participants, who 
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were asked about trial participation when some faced the “dreaded possibility that their 
baby would die.”   
 
The “breast and ovarian cancer” papers highlighted that nearly all the breast cancer patients 
“felt being in a life-threatened situation” although none reported feeling ill prior to  
treatment. Further, the authors drew attention to potential participants’ “fear” and 
“loneliness” at the time of being offered trial entry. The “stroke” paper described how some 
potential trial participants were experiencing “panic” and “anxiety” about further 
deterioration during the first few hours after stroke onset. 
 
The “leukaemia” paper considered parents of children with newly diagnosed, life-
threatening, acute lymphoblastic leukaemia who had been approached about entering their 
child into a trial which aimed to determine appropriate treatment. Parents expressed “very 
little negativity” about the trial, commenting only on the timing of the trial offer and having 
to make a relatively quick decision about randomisation so soon after diagnosis.  
 
Communication and relationship with trial recruiters 
Life-threatening circumstances apparently made potential trial participants’ perceptions of 
trial recruiters particularly salient.  The “pre-term labour” paper (a), reported the centrality 
of “socio-emotional” aspects of interpersonal exchanges to responses to recruitment 
invitations.  Women attributed their decisions to take part in the trial more to the health 
professionals who approached them rather than to any written trial information provided or 
to thoughts about the trial interventions or processes.  The authors suggested that the 
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importance of the interpersonal relationship was heightened by the women’s stress-
compromised ability to absorb information. 
 
Relationships with recruiting clinicians were also considered “highly influential” in the 
“perinatal” paper. The authors highlighted the significance of recruiters’ presentations of 
the trial, particularly for “the inferences that parents drew” about the risks and time 
available for deciding about participation. Where a need for an immediate decision was 
perceived, a particular “type of trust” became apparent and some parents took “a leap of 
faith” not necessarily based on “a particularly clear understanding of what they were being 
offered.”  
 
The importance of relationships between recruiting clinicians and patients also featured in 
the “breast and ovarian” papers. Some women’s feelings of “loneliness” and “emotional 
turbulence” were reflected in a “need for confidence and trust” in the doctor. This need was 
reinforced because women felt “life threatened and lacked sufficient medical knowledge to 
make educated choices.”  
  
Similarly in the “stroke” paper, information about the trial appeared less important to 
patients’ decisions than feelings of trust towards recruiting clinicians; a “tendency to 
perceive the information as a recommendation” was also reported. In the “leukaemia” 
paper there was little discussion regarding communication or trust issues per se, but the 
offer of trial participation was given in the same consultation as the diagnosis and the 
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authors highlighted the “dual” role of recruiting clinicians in terms of clinical management 
and research.  
 
Trial interventions and processes 
The interventions being evaluated in the “pre-term labour” papers were available outside 
the trial but not in the same context or combination. The authors reported that, although 
women acknowledged some uncertainty about whether the interventions would benefit 
their babies, they rationalised that outcomes would be “at worst no different from not 
taking part”, and some women believed that there was “no risk” to taking part. This 
apparently “intensified the feeling that there was no choice about whether to participate.” 
Women who expressed more concern about the risks of taking drugs in pregnancy seemed 
to weigh these against the possibly greater risks associated with premature birth.  
 
The trials in the “perinatal” papers compared a range of drugs. Some, but not all, had been 
shown to be effective against placebo. The authors suggested that decisions for 
participation signified to parents that they were doing everything they could for their 
children (including gaining access to a potentially beneficial experimental treatment), while 
decisions against participation signified they were protecting children from the potential 
harm of a (risky) experimental treatment. The authors identified a “disproportionate focus 
on benefits rather than risks” among participants.   
 
The three trials considered in the “breast and ovarian cancer” papers evaluated 
experimental treatments that were unavailable outside the trials. The authors reported that 
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almost all women perceived the ‘new’ treatments as superior, and that the prospect of 
randomisation appeared to cause some distress to women keen to access them. The 
availability of treatment interventions outside the trial studied in the “stroke” paper was not 
reported. Potential participants were strongly convinced of the importance of starting 
treatment, but did not seem fully aware that trial participation was voluntary.  The authors 
judged that “time pressure and anxiety during the first few hours after stroke onset … 
restricted the possibility of a free choice”  
 
Common good and identity implications   
 “Pre-term labour” paper (a), highlighted that a desire to help other women and their 
unborn babies at risk of a pre-term birth was important, reflecting a “strong sense of 
solidarity with other women.” However, the authors emphasised that acting on these 
feelings was “conditional on there being no risk” to themselves or their unborn children. 
“Pre-term labour” paper (b) discussed how some trial participants perceived that “an 
invitation to serve the public good” enabled them to demonstrate their “moral character,” 
but also recognised that in this life-threatening context “it would not be seen as morally 
deviant to decline the invitation.”   
 
The “perinatal” paper highlighted the “symbolism” of trial participation decisions: these 
decisions gave parents an opportunity for “involvement” and some control at a time of 
great uncertainty when there was little else they could do for their child.”  
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The importance of helping with research featured strongly in the accounts reported in the 
“stroke” paper, but the authors noted that a general consensus towards helping with 
furthering medical research could become detached from a specific personal choice about 
taking part or not in the trial. Similarly the very positive attitudes that women in the “breast 
and ovarian cancer” papers expressed towards clinical trials in general seemed to become 
less important when they faced more “personal choices” about trial involvement.   
 
The authors of the “leukaemia” paper reported many parents had a clear understanding 
that the scientific imperative of the trial was to help future children rather than explicitly 
helping their own child. However, few parents expressed “positive feelings” about helping 
future children (although agreeing to take part in the trial), reflecting possibly their 
immediate concerns for their own seriously ill child  
 
Established long-term conditions 
Four papers focused on people who were invited to participate in trials because they had 
established long-term conditions: “decision aid” paper, 19 “lupus” paper,20 “migraine” 
paper,21 and “reflux” paper.22  
 
The “decision aid” paper differed from the others because the trial it considered was of 
decision-support tools intended to support choices between treatments, rather than of 
treatments themselves. The authors interpreted the offer of taking part in this trial as a 
broader “research experience” for people living with a long-term condition. 
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The “lupus” paper highlighted the importance of people’s perceived state of health at the 
time of the trial invitation. This seemed primarily due to the “unpredictable course” of the 
condition and the potential for it to “flare precipitously” if treatment regimes changed.  
 
The people invited to participate in the trial studied in the “migraine” paper all had 
migraines that had caused “major disruptions to their lives” for years. They had used a 
range of prescribed and over-the-counter medications as part of extensive self-management 
regimes.  Many were taking a substantial amount of medication that was currently not 
controlling their symptoms satisfactorily.  
  
To be eligible for the trial reported in the “reflux” paper, people had to have been receiving 
medication for the previous twelve months and to have well controlled symptoms. Study 
participants expressed different attitudes towards their symptoms and medication, 
including long-term reliance on medication for symptom control.  
 
Communication and relationship with trial recruiters 
In this group, only the “lupus” paper reported interaction or relationship with trial recruiters 
as potentially significant for participation. Most of the people studied indicated that the 
recruiting physician’s opinion had “influenced their decision”, but participants to this trial 
were recruited by their usual clinicians, and many had developed strong relationships with 
these over a number of years.  In the other three papers, potential trial participants were 
mostly reviewed by clinicians who were not usually involved in their care. 
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Trial treatment interventions and processes  
The “decision aid” paper reported that some people valued the trial consultation as an 
“opportunity for an additional medical assessment or as a question and answer research 
meeting.” The “lupus” paper highlighted the significance of the ways trial interventions and 
processes related to people’s existing (already complicated) medical regimes for their 
decisions about participation.  
 
The “reflux” paper reported that personal invitations to undergo specialist assessment of 
their condition and discuss possible trial participation, along with perceptions of additional 
monitoring as part of trial follow-up, tended to influence decisions towards participation.  
Both interventions compared in this trial were available outside the trial, and potential 
participants already took the medication. Potential participants considered the benefits and 
risks of the surgical intervention, including associated pre-surgical tests and hospital stays. 
Those who saw the surgical intervention as an opportunity to improve their symptoms 
and/or to stop taking long-term medications thought they might benefit from trial 
participation. Some also thought they might access surgery more quickly in the trial. 
 
The “migraine” paper reported that some participants had used acupuncture previously 
with variable results, but as their current medication was not controlling their symptoms 
very well, they were inclined to consider acupuncture as an alternative.  Participants also 
seemed to derive confidence from the university setting of the trial and liked “the flexibility 
in appointments” and “the fact treatment was free.”  
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Common good and identity implications 
The “decision aid” paper discussed people’s sense of identity in relation to trial participation 
in some depth and described three main identity types. ‘Volunteers’ emphasised their 
desire to help others, albeit with expectation of some “indirect personal benefit.” ‘Patients’ 
perceived the trial primarily as an opportunity to benefit from individualised, tailored care, 
and those with a ‘hybrid identity’ had characteristics of both ‘patients’ and ‘volunteers’.   
 
The “lupus” paper reported a strong sense of altruism as important for some people 
although “not the only factor” for those considering trial participation. Feelings of altruism 
seemed particularly linked to a sense of “responsibility” towards future patients. 
  
The “migraine” paper identified a “desire to help with the research” as a feature of people’s 
decision-making. However, the authors suggested that decision-making was influenced 
primarily by people’s desires for improvement in their condition. The “reflux” paper 
reported an inclination to help others or contribute to a collective general good that 
predisposed people towards trial participation. However, the authors stressed that 
decisions ultimately depended on how people thought participation might impact on them 
personally, conceptualising this as “conditional altruism”.  
 
Recently diagnosed long-term conditions  
One paper, the “epilepsy” paper4, focused on people who had been very recently diagnosed 
with a long-term condition when they were asked to participate in a trial.  
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Similar to the situation in the “leukaemia” paper, trial recruitment consultations began with 
the clinician confirming a diagnosis. The diagnosis of epilepsy was reported as “generally 
unwelcome and for some, something of a shock.” People had to accept both diagnosis and 
the need for treatment before they were invited to participate in the trial. Some appeared 
“unprepared” for discussions about long-term drug treatment and possible participation in a 
trial comparing different regimens.  
 
Communication and relationship with trial recruiters 
Communication with recruiting clinicians was noted as particularly salient in this paper. The 
authors highlighted that participants’ accounts were “reflective of trust” in the doctor, even 
though this was often their first encounter, and that trust seemed important for decisions 
about participation. 
 
Trial treatment interventions and processes  
All drugs being compared in the epilepsy trial were available outside the trial, although two 
were not then licensed for monotherapy. The authors observed that trial acceptors thought 
the drugs being compared in the trial had been “tested and were safe” so perceived trial 
participation as a “low-risk enterprise.” Some also thought their care within the trial would 
be tailored to their individual needs. 
 
Common good and identity implications  
The authors suggested that attitudes towards trial participation could be characterised by a 
combination of a sense of “altruism or duty” and “personal desire and self-interest.” People 
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articulated a strong sense of “moral duty” to take part and of the importance of 
contributing to scientific knowledge, but were “happy to help others… only where they 
could also help themselves”. The authors conceptualised this as “weak altruism.” 
 
 
LINE OF ARGUMENT 
As indicated above, our line of argument synthesis highlights the significance of the way 
potential participants were situated in terms of their health states, treatment junctures, and 
perceptions about these at the time of trial recruitment. Potential participants’ sense of 
their situation can influence the nature and salience of judgements about: communications 
and relationships with trial recruiters; trial interventions and processes; and the implications 
of trial participation decisions for the common good and their own identity. All of these 
judgements can shape decisions about trial entry, although their particular significance 
varies between and within condition groups. Figure 2 illustrates the line of argument 
developed from the second synthesis. 
 
The above summary suggests several emergent patterns. Interpersonal interactions and 
relationships between potential trial participants and trial recruiters can be particularly 
important when people find themselves (or their children) in urgent, unfamiliar and 
apparently life-threatening situations. In part this may be because fear impairs information 
processing3 and loneliness enhances the need for relational support.17 The advice of trusted 
clinicians can also be particularly important for people with long-term conditions if trial 
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participation might involve a change of treatment that threatens the stability of their 
condition.  
 
People sometimes perceive invitations to participate in trials as personal recommendations 
from recruiting doctors. The practical and ethical implications of this depend on the nature 
of their relationship (e.g. ‘usual’ or ‘trial-specific’) and the duration and quality of 
interactions between them.  
 
The features of trial interventions and processes are obviously salient for people’s decisions 
about trial entry, although their significance depends on how they are perceived and 
considered in relation to other issues. Perceptions of trial interventions as potentially 
beneficial and “low risk” incline people to participate, and some people strongly value trial 
participation as a means of possible access to treatments that are unavailable otherwise. 
Perceptions of trial interventions as more risky, on the other hand, can render declining 
participation as the better (because safer) option. In general, people may perceive the risks 
of trial participation as lower if all the interventions being compared are licensed for at least 
some kinds of clinical use, although judgements about the risks of these interventions still 
vary.  
 
Attitudes towards participating in a trial can often be characterised by a sense of wishing to 
contribute towards the greater good, and thus demonstrating a positive moral identity, but 
also being concerned about self-interest. Self-interest considerations might be particularly 
strong among people in relatively ‘good’ situations that could be threatened by trial 
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participation. Some reports of the significance of trial participation as a moral imperative 
may have reflected more of a post-trial decision rationalisation than a prospective influence.  
 
[Insert Figure 2] 
 
Comparison with first synthesis 
Our two meta-ethnographic syntheses were broadly compatible, but the second more 
clearly indicated how participants’ health-related situations can mediate the significance for 
people’s decisions about participation of key features of recruitment processes (including 
relationships with trial staff), of the interventions and processes involved in particular trials, 
and of participants’ general inclinations to support research.  
 
Discussion 
Our second synthesis highlighted the significance of potential participants’ health states and 
healthcare situations at the time of recruitment for mediating their interpretations and 
weighing up of: (a) communication and relationships with trial recruiters; (b) trial 
interventions and processes; and (c) common good and personal identity considerations. 
Trialists need to consider these issues when designing recruitment approaches.  
 
Our literature searches were systematic, although searching for qualitative studies is a 
complex challenge and still requires further investigation.23  We only included papers 
published in English and the 12 papers in this second meta-ethnography represented only 9 
studies, so there may have been some over-representation of particular concepts and ideas. 
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The available studies did not cover the range of health-related trial situations 
comprehensively.  
 
When we conducted the second “stand-alone” meta-ethnography, we were inevitably 
somewhat sensitised to the findings of the first, although we refrained from referring back 
to this until the second synthesis was completed. We were also particularly familiar (as 
authors) with one of the papers22 included in the second synthesis. However, the 
interpretive process of synthesising translations will always to some extent reflect the 
particular backgrounds of the research team involved.  
 
On reflection, given the broad similarities of our two syntheses, our concerns about “forcing 
a fit” by trying to incorporate subsequently published studies into our first synthesis were 
perhaps too strong. However, if such a strategy had been adopted we would probably not 
have made the refinements to the initial line of argument that were facilitated by our 
decision in the second meta-ethnography to group studies according to the health and 
health care situations of potential participants at the time of recruitment.  
 
Further investigation and debate about processes for updating meta-ethnographic 
syntheses will become increasingly important as more time elapses since early syntheses.    
This study provides the first empirical insights into the updating process that we are 
currently aware of.  Our experience has suggested that a ‘standalone’ update can be 
appropriate, and consideration could be given to different kinds of study sampling 24 
including time based approaches. These might be particularly useful when substantial 
numbers of relevant papers are available.  
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